Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit ...

Retrieved on: 2024-10-13 16:17:08

Tags for this article:

Research and development in the United States

Click the tags to see associated articles and topics

Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit .... View article details on hiswai:

Summary

The article discusses investment prospects in biopharma, focusing on Viking Therapeutics and Summit Therapeutics, emphasizing their R&D efforts to capture market shares dominated by Eli Lilly and Novo Nordisk in the U.S. biopharma industry.

Article found on: www.theglobeandmail.com

View Original Article